Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia

Trial Profile

Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
  • Indications Hyperphosphataemia; Renal failure
  • Focus Therapeutic Use
  • Acronyms LAVALIER
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Sep 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 20 Apr 2015 Status changed from not yet recruiting to recruiting as ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top